Skip to content
Search

Latest Stories

All contractors including ‘outliers’ to receive Covid cost payments in October

All contractors in England, including those identified as “outliers”, will receive a payment for their submitted Covid-19 related costs in early October, Pharmaceutical Services Negotiating Committee (PSNC) has said.

This follows finalisation of arrangements for payment of contractors’ Covid cost claims by the Department of Health and Social Care (DHSC) and NHS Business Services Authority (NHSBSA).


PSNC said in an update that more than 9,900 contractors have submitted claims for their Covid-19 related costs over the summer, which amounted to more than double the £120 million offered initially by the government.

Last week, PSNC outgoing chief executive Simon Dukes had assured all contractors will receive a payment at the start of October with almost 95 per cent of them receiving their claims in full.

Meanwhile, “outliers” will be paid one sixth of the additional advance payments they received, while their claims are being verified, the negotiator explained.

Some contractors’ claims will be further verified before the payment, including:

  • Claims exceeding one third of annual NHS income in 2020/21 for contractors who opened after March 2019 or an average of 2019/20 and 2020/21 income for contractors who opened before March 2019
  • Claims where initial review identifies a risk of a potential error that could result in a significant overpayment – eg where claims are likely to fall outside the categories for which contractors were eligible to claim for.

In case the claim remains outstanding for another month, the contractor will be again paid one sixth of the additional advance payments in November, unless the submission is not supported with evidence, PSNC said.

The NHSBSA will also conduct post-payment verification on claims, and can ask contractors to submit the evidence within five working days.

The negotiator said an amendment will be made to the Drug Tariff to reflect these arrangements.

Dukes said: “We have been clear that all contractors must receive a payment in October as last year’s additional advance payments start to be repaid.

“For the very small number of contractors whose claims need to be verified first, the payment of one sixth of the value of their additional advance payments balances the immediate need to support cashflow at this time with the risks of significant cashflow disruption should large claims need be reduced after verification.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less